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new vessel.
In this paper we present a new approach to angiogenesis, based on the theory of reinforced random walks,
coupled with a Michaelis-Menten type mechanism which views the endothelial cell receptors as the catalyst
for transforming angiogenic factor into proteolytic enzyme in order to model the first stage. In this model, a
single layer of endothelial cells is separated by a vascular wall from an extracellular tissue matrix. A coupled
system of ordinary and partial differential equations is derived which, in the presence of an angiogenic agent,
predicts the aggregation of the endothelial cells and the collapse of the vascular lamina, opening a passage into
the extracellular matrix. We refer to this as the onset of vascular sprouting. Some biological evidence for the
correctness of our model is indicated by the formation of teats in utero. Further evidence for the correctness of
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MATHEMATICAL MODELING OF THE ONSET OF CAPILLARY FORMATION
INITIATING ANGIOGENESIS
HOWARD A. LEVINE & BRIAN D. SLEEMAN & MARIT NILSEN-HAMILTON
Abstract. It is well accepted that vascular neoformation can be divided into three main stages (which may
be overlapping): (1) changes within the existing vessel, (2) formation of a new channel, (3) maturation of
the new vessel.
The purpose of this paper is to present a simple model, based on the theory of reinforced random walks,
coupled with a Michaelis-Menton type mechanism which views the endothelial cell receptors as the catalyst
for transforming angiogenic factor into proteolytic enzyme in order model the rst stage. In this model, a
single layer of endothelial cells is separated by a vascular wall from an extracellular tissue matrix. A coupled
system of ordinary and partial dierential equations is derived which, in the presence of an angiogenic agent,
predicts the aggregation of the endothelial cells and the collapse of the vascular lamina, opening a passage
into the extracellularmatrix. We refer to this as the onset of vascular sprouting. The model admits extension
to several angiogenic agents as well as to angistatic agents (angiostatins). Indeed, we give a mathematical
denition of what it means to be angiogenic or angiostatic.
1. Introduction
To understand the mechanisms of capillary sprout formation as a result of endothelial cell migration is
fundamental to vascularization in many physiological and pathological situations. For example evidence
that most capillary growth in the rat heart takes place in the early stages of post natal development [22, 28]
was followed by the ndings of concomitant changes in the expression of various growth factors [5, 6].
However this interaction is not fully understood; particularly in the study of endothelial cell growth. There
is well documented evidence that results from \in vitro" studies cannot be automatically extrapolated to
the situation \in vivo". Indeed transforming growth factor (TGF) which suppresses the proliferation of
endothelial cells in vitro has an overall angiogenic eect in vivo. [28].
Capillaries are remarkably stable structures. For example the turnover of endothelial cells in the adult
mammalian heart is probably slightly faster than in most other tissues. Nevertheless the cell half-life is
estimated to be approximately 300 days [10]. Most of the formation of new vascular material normally
constitutes replacement of damaged cells and re-population of denuded areas in the pathological processes
such as wound healing.
However, in the development of tumors capillary growth through angiogenesis leads to vascularization of
the tumor, providing it with its own blood supply and consequently allowing for rapid growth and metastasis.
It is important to distinguish the main features of vascularization; that is vasculogenesis and angiogenesis.
Vasculogenesis is dened as the formation of new vessels in sites from pluripotent mesenchymal cells (e.g.
angioblasts) whereas angiogenesis is dened as the outgrowth of new vessels from a pre-existing network. We
shall be concerned with angiogenesis. Both vasculogenesis and angiogenesis have been documented during
prenatal development of mammalian hearts [10, 20, 22]. For example in the case of the rat heart, up to day
10 post-fertilization the endocardium is smooth, and the only mode of oxygen transport is by diusion. This
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is followed by vasculogenesis in the form of sinusoids lined by a very thin endothelium which are located
within the spongy musculature. Angiogenesis follows in the form of sprouts emanating from the branches
of coronary arteries, starting in the subepicardial layer and proceeding towards the sinuses located in the
endomycardium. The newly formed vessels may subsequently regress or persist as capillaries or they may
progress to form larger vessels of arterial or venous type.
Vascular growth is a complex phenomena involving the mechanisms of angiogenesis. These include me-
chanical factors in which there is an increased red blood cell - endothelial interaction, as in polycythemia, an
increased wall tension as a result of increased capillary pressure and an increased shear stress resulting from
increased velocity ow. Energy imbalance is another factor wherein there is a prolonged imbalance between
the perfusion capabilities of blood vessels and the metabolic requirements of tissue changes in oxygenation
may have a major triggering and controlling element. Inammatory processes may also be associated with
the activation of endothelial cells and possibly platelets; both of which express the adhesion molecules for
monocytes. Monocytes are a possible major source of angiogenic growth factors. For a discussion of these
issues we refer the reader to [1, 9, 25, 27].
The precise mechanisms of vascular growth are complex and not well understood. The role of various
growth factors has been considered by [7, 12, 13]. The eects vary depending on the environment and the
concentration of these factors with dierent results obtained under in vivo and in vitro conditions.
The most often cited angiogenic peptides which are eective both in vivo and in vitro are acidic and
basic broblast growth factors (FGF), vascular endothelial growth factor (VEGF) and vascular permeability
factor (VPF), transforming growth factor alpha (TGF) and related epidermal growth factor (EGF).
The factors VEGF, VPF and PD-ECGF (platelet-derived endothelial all growth factor) are mitogenic
factors highly specic for endothelial cells and VEGF may be induced by hypoxia. In addition to these factors
which are endothelial cell mitogens, there are angiogenic factors which are not mitogenic (e.g. angiogenic) or
are even inhibitory to endothelial cell proliferation in vitro. For example these include transforming growth
factor beta (TGF) and tumor necrosis factor  (TNF).
In addition to the angiogenic factors, vascular growth can be further modied and regulated by local
geometric conditions; endothelial cell size and shape and the location of other cell types such as smooth
muscle cells, pericytes, platelets, macrophages and mast cells.
The complexity of the endothelial growth process and the large number of apparently redundant angiogenic
factors may be an indication [12] of the vital importance of the process itself. Indeed the ne tuning and
interaction of the above systems maintains this delicate balance for the optimal arrangement of vascular
geometry.
At the present time it appears to be a formidable task to develop a complete mathematical model of
angiogenesis which incorporates all of the above complex processes. It is desirable nevertheless to attempt
to describe a portion of this process. This paper therefore concentrates on the importance of some of the
angiogenic factors involved. In particular it focuses on the angiogenic factors associated with the neovascular
phase of solid tumor growth.
To this end we rst discuss the major morphological components of the stable vessel which are potentially
involved in the process of angiogenesis. The most prominent are the at endothelial cells themselves. Typ-
ically two endothelial cells are required to encircle the capillary Lumen. These cells are not to be regarded
as simply a passive lining of the micro-vessels, but rather as a composite in a large and extremely active
endocrine organ. The capillary as a whole is wrapped in a basement membrane which is only a fraction of
the thickness of the endothelial cells. The basement membrane also covers infrequently occurring pericytes
which are similar to smooth muscle cells. Pericytes possibly contribute to the regularization of the vessel size
and control the proliferation of endothelial cells. This regulation requires cell-to-cell contact - and maybe
mediated by TGF, which suppresses endothelial cell proliferation.
Macrophages and activated platelets are also important and sometimes major sources of angiogenic factors
involved in all stages of vessel formation. [3, 27, 29].
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It is now well accepted, [21, 25], vascular neoformation can be divided into three main stages (which may
be overlapping):
1. changes within the existing vessel.
2. formation of a new channel.
3. maturation of the new vessel.
The entire process is nicely illustrated schematically in Figures 1, 2 which are taken from [14, 24] respec-
tively. This paper concentrates on stage 1, while the modeling of stages 2 and 3 will be the subjects of
further work.
In stage 1 one of the primary events is the dilation of the vessel. This is followed by the activation of the
endothelial cells which as a result of their stretching show an increased sensitivity to various growth factors.
The endothelial cells respond by secreting plasminogen activator and a variety of proteolytic enzymes which
dissolve the extra-cellular matrix where the growth factors such as FGF are stored.
Subsequently the basement membrane becomes disrupted and local extravasation takes place. Leaked
brin and its products serve as a provisional matrix for future growth. Also, the activated endothelial cells
start to synthesis new DNA while they are still in the parent vessel. Additional growth factors are provided
by nearby activated platelets and macrophages.
In regard to tumor growth angiogenesis is initiated by the release of angiogenic factors from the tumor.
In response to this stimulus activated endothelial cells in nearby capillaries appear to thicken and nger-
like protrusions can be observed on the abluminal surface [2, 21]. Cell associated proteases degrade the
basement membrane allowing the EC's to accumulate in the region where the concentrations of TAF reaches
a threshold [21]. The vessel wall dilates as the EC's aggregate to form sprouts. The EC's as described above
release proteolytic enzymes which dissolve the basal lamina and ECM enabling the capillary sprouts to grow
towards the tumor [11].
With this motivating background we now focus on the development of mathematical models of the rst
stage of angiogenesis. The plan of this paper is as follows:
2 Mathematical Models
2.1 Enzyme Kinetics
2.2 Random Walk
3 Capillary sprout formation
3.1 Auto-enzyme production case
3.2 Angiogenic factor driven case
3.3 A remark on mitogenesis
4 Numerical experiments
4.1 Auto-enzyme production case
4.2 Angiogenic factor driven case
5 Cautionary note on numerics
6 Several proteolytic/ angiogenic /aptotactic Factors
6.1 Auto-enzyme production case
6.2 Angiogenic factor driven case
7 Summary
8 Discussion
2. Mathematical Models
A mathematical model describing the onset of capillary sprouts in tumor angiogenesis has been developed
in [18]. In this model the authors concentrate on the role of haptotaxis to regulate all movement due to
the release of bronectin which increases cell-to-matrix adhesiveness and also serves as a provisional matrix
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for future growth. The model is based on reaction-diusion mechanisms and capillary sprout formation is
accounted for through Turing - diusion driven instability [16, 30].
Here a somewhat dierent-point-of view is oered, based on the idea of reinforced random walks [4]. This
idea was developed and exploited in [19] to describe the movement of living organisms that deposit a non-
diusible substance (signal) which modies the local environment for subsequent movement. The particular
organisms studied are the micro bacteria particularly myxococus fulvius and dictyostelium discoidium. In
the continuum limit Othmer and Stevens [19] derive a system of evolutionary equations which may exhibit
nite-time blow up of solutions, decay to a spatially constant solution, or nonconstant, piecewise constant
solutions (aggregation). In [15] the authors have provided detailed rigorous and semi-rigorous arguments
which support the existence of aggregation. We believe that aggregation is an important component of
sprout formation.
In the next section we discuss the enzyme kinetics we wish to employ in our model. In the subsequent
section, we apply the ideas of random walk discussed above to the vascular wall.
2.1. Enzyme Kinetics. In order to better understand how the angiogenic factor acts on the endothelial
cells, we consider a simplied version of Figure 1. That is, we consider that each cell has a certain number
of receptors to which the angiogenic factor (ligands) bind. The bound molecules (intermediaries) in turn
stimulate the cell to produce proteolitic enzyme and form new receptors.
We model this process as follows:
V +R
k
1

k
 1
RV(2.1.1)
RV
k
2
 ! C + R
0
R
0
k
0
2
 ! R
C
k
3
 ! Q
where V denotes the angiogenic factor (substrate), R denotes some receptor site on the endothelial cell
wall, RV is the intermediary, C is the proteolytic enzyme produced by this reaction, R
0
is an intermediary
ligand-like molecule which then exits the cell to produce a receptor of the original type R at the cell surface
and nally Q is a product produced as the protease degrades the laminar wall. The point of view here is
that the receptors at the surface of the cell function the same way an enzyme functions in classical enzymatic
catalysis.
We shall take a somewhat simplied version of this mechanism as follows;
V + R
k
1

k
 1
RV(2.1.2)
RV
k
2
 ! C +R
C
k
3
 ! Q
This presupposes that the third step in (2.1.1) is irreversible.
We adopt the following notation (concentrations are expressed in moles per unit length):
v = concentration of angiogenic factor, V
c = concentration of proteolytic enzyme, C
r = density of receptors on the cell directed into the basement lamina, R(2.1.3)
` = concentration of intermediate receptor complex,RV
 = concentration of endothelial cells
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These variables depend on (x; t): Hence we use @=@t to denote time rates of change. Then the law of mass
action gives
@r
@t
=  k
1
rv + (k
 1
+ k
2
)`
@`
@t
= k
1
rv   (k
 1
+ k
2
)`
@v
@t
=  k
1
rv + k
 1
`
@c
@t
= k
2
`   k
3
c
We make two hypotheses about this system:
H1 The reaction proceeds so rapidly that
@`
@t
 0: This is essentially the original Michaelis-Menton hypoth-
esis.
H2 r(x; t) is proportional to (x; t) and on the time scale of the above hypothesis, we can write r(x; 0) 
(x; t):
From the rst two equations and the second hypothesis we can write
r(x; t) + `(x; t) = r(x; 0)  (x; t):
since there is no intermediate present initially. Using this and the consequence of setting `
t
= 0; we obtain,
after some algebra
@v
@t
=
 v
1 + v
(2.1.4)
@c
@t
=
v
1 + v
  c
where we have set  = k
1
=(k
 1
+ k
2
) k
3
=  and  = k
2
:
Typically, for reaction mechanisms such as (2.1.4) we have that k
2
<< k
1
; k
 1
<< k
1
and k
1
is very large.
In particular, this means that  = k
1
>> 1:
In this paper we shall rst replace (2.1.4) by
@c
@t
=
c
1 + c
  c:(2.1.5)
The rational behind this is that we want to test the mechanism for the eect of the auto-production
mechanism for our full model before proceeding to the full set of equations (2.1.4.) This test is useful
because we can think of (2.1.5) as a Michaelis-Menton type kinetic equation. We could also imagine that
proteolytic enzyme production could be set o in a cell by radiation or some other external stimulus other
than by a chemical bullet such as angiogenic factors.
More importantly, the system that employs (2.1.5) is much easier to analize than the one that includes
(2.1.4). This is true even in the simple subcases for which  =  = 0: Therefore, we shall simply carry out
a few numerical experiments for our full system when we employ (2.1.4).
2.2. Random Walk. In order to understand the idea behind the notion of reinforced random walks, we
consider the parent capillary wall to be a one-dimensional lattice with endothelial cells (assumed to be a
mono layer of equal size and shape) equally spaced and in non-overlapping contact located at reference points
nh along the x-axis.
At rst we imagine a distribution of endothelial cells at lattice points x
n
= nh on the real axis. We let
^

n
() be the transition probability/unit time for a one-step move of an endothelial cell at site n to site n+1
or n   1. Let 
n
(t) be the probability density distribution of the endothelial cells at position n at time t:
Then the time rate of change of 
n
(t) is governed by the master equation
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@
n
(t)
@t
= ^
+
n 1
(W )
n 1
+ ^
 
n+1
(W )
n+1
  (^
+
n
(W ) + ^
 
n
(W )
n
:(2.2.1)
That is, 
n
will be augmented by cells moving from the positions (n 1)h to nh and diminished by cells
moving from nh to either(n + 1)h or (n  1)h: The quantity (^
+
n
(W ) + ^
 
n
(W ))
 1
is the mean waiting time
at site n.
It is convenient to think of this conditional probability density as the density of endothelial cells. The
point of view adopted here is the same as in quantum mechanics where an electron can be thought of as a
probability density or else as a \ cloud of negative charge."
The transition probability rates ^

n
() depend on control substances which we have denoted by W and
are dened on the lattice at
1
2
-step size. The control substances W are very general and can include all the
enzymes which are generated by the growth factors described above i.e., (FGF), (VEGF), (TGF), (TGF)
etc. As remarked above, in this paper, we concentrate on the important role of secreted bronectin and
proteolytic enzyme which dissolves the ECM and ruptures the basement membrane. Denote the density of
bronectin by f and the concentration of proteolytic enzyme by c. The control substance W is represented
as the vector of components.
W = (:::W
 n 
1
2
;W
 n
;W
 n+
1
2
; :::)(2.2.2)
where W
n
= W (f; c) is a function of f and c.
While the basic model (2.2.1) can be exploited [19] to describe many aspects of organism dynamics it
gives no restriction on the transition rates at a site and there is no correlation between transition rates to
right or left.
Suppose, as suggested in [19], that the decision of \when to move" is independent of the decision of \where
to move". Then the mean waiting time of the process is constant across the lattice. Hence the transitions
^

n
may be suitably scaled and normalized. Let the scaled and normalized transition rates be N

n
(W ) and
depend on W only at the nearest neighbors W
n+
1
2
;W
n 
1
2
.
Then
N
+
n
(W ) +N
 
n
(W ) =
1

(2.2.3)
and
N

n
(W ) =
^ (W
n
1
2
)
^ (W
n+
1
2
) + ^ (W
n 
1
2
)
;(2.2.4)
where, in (2.2.3),  is a scaling parameter.
The master equation now reads
@
n
@t
= N
+
(W
n 
1
2
;W
n 
3
2
)
n 1
+ N
 
(W
n+
1
2
;W
n+
3
2
)
n+1
  [N
+
(W
n+
1
2
;W
n 
1
2
) + N
 
(W
n 
1
2
;W
n+
1
2
]
n
:
(2.2.5)
We now proceed to the continuous limit by letting h! 0 and ! +1 in such a way that
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D =
1
2
lim
h!0;!+1
h
2
:(2.2.6)
(See [15, 19] for details) to obtain the primary equation, which we shall refer to as the continuous limit of
master equation (CLME):
@
@t
= D
@
@x


@
@x

ln

^


(2.2.7)
where (x; t) now denotes endothelial cell density and ^ = ^ (w) = ^ (w(f; c)).
The production of bronectin is modeled through a logistic growth term f(1  f) together with a term
describing the up-take of bronectin by the EC, f. This yields the additional dynamical equation and
initial condition:
@f
@t
= f (1  f)    f;(2.2.8)
f(x; 0) = f
0
(x)  0:
We also have in addition to (2.2.7), (2.2.8), the following dynamical equation and initial conditions:
@c
@t
=
c
1 + c
  c;(2.2.9)
c(x; 0) = c
0
(x)  0
where we are now using (2.1.5) instead of (2.1.4) as explained in the preceding section.
The system is closed by assuming no-ux boundary conditions at x = 0; `, i.e.

@
@x

ln

^

= 0 at x = 0; `:(2.2.10)
To complete the model we suppose the transition probability rate function ^ to be factored as
^ (w (f; c)) = ^
1
(f) ^
2
(c)(2.2.11)
and choose
^
1
(f) = f
 =D
(2.2.12)
leading to a haptotatic sensitivity

f
=
^
0
1
(f)
^
1
(f)

 
Df
:(2.2.13)
We also assume that 
2
(c) has the form
^
2
(c) = c

0
=D
(2.2.14)
giving a chemotaxic sensitivity
^
0
2
^
0
2
= 
c
=

0
Dc
:(2.2.15)
We shall say that the sensitivity factors (2.2.13),(2.2.15) are \ power law sensitivity factors". The choice
of the transition probability ^ adopted here is to provide a measure of how responsive the EC are to various
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growth factors. In the case of tumor growth this would be for example due to the EC's enzymatic responses
to one or more of the tumor angiogenesis factors (TAF). The model is in this regard very exible and other
choices of ^ can be adopted, having other degrees of sensitivity depending on the particular angiogenic
process to be modeled. For example in [19] it is supposed that a signal is transduced via a receptor R which
binds with the signal w and that the response is proportional to the fraction of receptors occupied. The
binding reaction can be written as
R+ w
k
1

k
 1
[Rw](2.2.16)
where [Rw] denotes the receptor - signal complex. If binding comes rapidly to equilibrium on the time scale
of the evolution of  and w; then for the local sensing [19] choose a transition probability
^ (w) =
w
 +w
;(2.2.17)
where  is a constant that incorporates the total number of receptors and   k
 1
=k
1
.
In their work on modeling capillary endothelial cell-extracellular matrix interactions in wound healing,
the authors in [17] used a haptotaxic transition probability.
^ (m) = exp C (k +m)
 1
(2.2.18)
where C and k are constants and m is the brillar ECM density.
In the context of the present work, we are primarily interested in the mechanism of capillary sprouting
from the parent vessel as a result of aggregation of endothelial cells. It is therefore reasonable to suppose
that a primary mechanism for this is due to the sensitivity of the EC to angiogenic growth factors and
consequently on the form of the transition probabilities ^ (c; f). Therefore in Section 4 of this paper we shall
consider ^ (c; f) given by
^ (c; f) = ^
1
(c) ^
2
(f)
=


1
+ c

2
+ c


1


1
+ f

2
+ f


2
(2.2.19)
where 
i
; 
i
; 
i
are positive constants. We refer to the sensitivity factors coming from (2.2.19) as \saturable
sensitivity factors".
If we apply the scalings
t =
`
2
t
0

2
D
; x =
`x
0

;
 =

2
D
`
2

0
;  =

2
D
`
2

0
;
 =

2
D
`
2

0
;  =

2
D
`
2

0
;
(2.2.20)
then we can write the auto-enzyme production model in the non-dimensionalized form
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@
@t
=
@
@x


@
@x

ln

^


;
@c
@t
=
c
1 + c
  c;
@f
@t
= f (1  f)    f;
(2.2.21)

@
@x

ln

^

= 0; x = 0; :
together with the initial conditions
 (x; 0) = 
0
(x)  0;
c (x; 0) = c
0
(x)  0;
f (x; 0) = f
0
(x)  0:
(2.2.22)
On the other hand, if we use the full enzyme kinetic equations based on (2.1.1) as simplied in (2.1.4)
using the Michaelis-Menton hypothesis, we obtain the system
@
@t
=
@
@x


@
@x

ln

^


;
@v
@t
=
 v
1 + v
;
@c
@t
=
v
1 + v
  c;
@f
@t
= f (1  f)    f;
(2.2.23)

@
@x

ln

^

= 0; x = 0; :
together with the initial conditions
 (x; 0) = 
0
(x)  0;
v (x; 0) = v
0
(x)  0;
c (x; 0) = c
0
(x)  0;
f (x; 0) = f
0
(x)  0:
(2.2.24)
Notice that in this form of the model, ^ = ^ (c; f): That is, we expect  to depend upon v through c. For
example, in the most important case is the case for which all of the initial conditions in (2.2.24) are constant
except v
0
. This means that in order that the angiogenic factor drive the endothelial cells, we must have
^ = ^ (c; v(c); f):
3. Capillary Sprout Formation
In this section we analyze various sub cases of the model above.
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3.1. Auto-enzyme production case. Here we consider the system (2.2.21)-(2.2.22). (That is, in the case
of proteolytic enzyme production given by (2.1.5.) To this end we consider an extreme situation whereby
rigorous exact solutions may be found and which illustrate the initiation of sprout formation. To illustrate
the type of phenomena to be expected consider  = 0 in the second of equations (2.2.21), i.e. non-saturating
growth, Then on setting c = c
0
exp( t) and choosing (2.2.12), (2.2.14) for the transition probabilities, we
obtain the system
@
@t
=
@
2

@x
2
  
0
@
@x


c
x
c

+ 
@
@x


f
x
f

:
@c
@t
= c;
@f
@t
= f (1  f)    f;
(3.1.1)
subject to

x

+ 
f
x
f
  
0
c
x
c
= 0; at x = 0; 
together with the initial conditions (2.2.22).
Suppose, initially, the concentration of bronectin is small i.e. f
0
(x) = f

<< 1; then for small times the
third of equations (3.1.1) can be approximated by
@f
@t
= (   ) f:(3.1.2)
From the second of equations (3.1.1),and equation (3.1.2) we have
@
@t

ln c


=
@
@t

ln f
   

i.e.
ln c

=
lnf
   
+ lnd(x)
(3.1.3)
where d(x) is arbitrary.
Now dene the function  (x; t) by
 =
ln c

   ln d(x) =
ln f
   
+  ln d(x)(3.1.4)
for constants ;  such that  +  = 1.
From this it follows that
 
x
=
1

c
x
c
  
d
0
d
=
1
   
f
x
f
+ 
d
0
d
:
Consequently

0
c
x
c
  
f
x
x
= (
0
   (   )) 
x
+ (
0
 +  (   )  )
d
0
d
:
If we choose
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 +  = 1

0
 + (   )  = 0;
(3.1.5)
which is solvable provided

0
  (   )  6= 0;
then

0
c
x
c
  
f
x
f
= (
0
    (   )) 
x
:(3.1.6)
Furthermore, from (3.1.4)
 =
1

c
t
c
=  
t
:(3.1.7)
It follows that the function  must satisfy
L   
tt
+ (
0
   (   )) ( 
x
 
t
)
x
=  
xxt
(3.1.8)
L denes a quasi-linear second order partial dierential equation whose discriminant is
D = a
2
 
2
x
  4a 
t
(3.1.9)
where a = 
0
   (   ).
If D > 0 at a point (x; t) the operator L in (3.1.8) is hyperbolic, whereas if D < 0 it is elliptic and if
D = 0 then L is parabolic. Since (x; t) =  
t
is required to be positive we see that L is hyperbolic if a < 0.
However if a > 0 then D may be positive or negative. We refer to this as the mixed case.
Let us consider the mixed case rst. If we let (x; 0) have mean value  =
1

Z

0
(x; 0)dx then with
 = t+ u;(3.1.10)
u must satisfy
u
tt
+ au
xx
  u
xxt
=  a(u
t
u
x
)
x
; 0 < x < ; t > 0
u
x
(u
t
+ ) = u
xt
for x = 0; ; t > 0
Z

0
u
t
(x; t) dx = 0:
(3.1.11)
Following the approach of [15] we obtain the exact solution
 (x; t) = t+ 2
1
X
n=1
1
n
a
n

n
exp(Nnct) cos(Nnx)(3.1.12)
= t  ln[1  2ae
Nct
cosNx+ a
2

2
e
2Nct
]
where
12 HOWARD A. LEVINE & BRIAN D. SLEEMAN & MARIT NILSEN-HAMILTON
c =
2a
N +
p
N
2
+ 4a
(3.1.13)
is positive since a > 0.
Furthermore the series in the rst of (3.1.12) is absolutely and uniformly convergent on compact subsets
of [0; ] [0; T ) where
T  T (N; a")   
ln ja"j
Nc
:
From this we see that
 (x; t) =  +
1

u
t
=  + 2Nc
1
X
n=1
"
n
a
n
exp (Nnct) cos (Nnx)(3.1.14)
=    2Nca
a  cosNx
1  2ae
Nct
cosNx+ a
2

2
e
2Nct
which clearly is singular at t = T (N; a). In other words we have constructed a solution which \blows up"
in nite time. Notice that
 (x; 0) =  +
2Nc

1
X
n=1
"
n
a
n
cos (Nnx)
'  +
2Nc

"acosN
x
+ 0
 
"
2

:
This corresponds to an initial endothelial cell density which is a small (in ") perturbation about its mean
value. Furthermore \blow up" occurs at the points
 
2m 1
N
; T

where 0 < m <
N+1
2
. These \blow-up"
points may be thought of as initiating sites of capillary sprouts.
Alternatively if a =  
0
   (   ) < 0 then it can be shown (see [15] that (3.1.8) has solutions which "
collapse". Indeed, one nds, the \same" solutions:
 = t  ln[1  2ae
Nct
cosNx+ a
2

2
e
2Nct
]
 =    2Nca
a  cosNx
1  2ae
Nct
cosNx+ a
2

2
e
2Nct
but now
c

=
2a
N 
p
N
2
+ 4a
(3.1.15)
are both negative provided N
2
+ 4a > 0.
Of course this solution is formally the same as when a > 0 but the constant c is now always negative
and hence  decays to a constant as t ! +1: That is, capillary sprouts do not form. For this to occur we
must have (   ) > 0 with sucient haptotatic sensitivity. This means that if  <  so that bronectin
is being consumed, then  < 0 also, so that the the haptotatic sensitivity factor is positive and large, i.e.,
there is motility of bronectin into the region of high endothelial cell concentration, at least for low levels of
bronectin.
Having determined the structure of  in terms of the behavior of  we see that the concentration of the
proteolytic enzyme c is given by
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c(x; t) =  

(x; t)  d

(x):(3.1.16)
whereas the bronectin concentration is
f(x; t) =  
( )
(x; t)  d
 
(x)(3.1.17)
where     < 0 and  +  = 1.
Consider once again the case
a = 
0
  (   ) > 0:
Here we know that sprouts will form (\blow up" case) and from (3.1.16)-(3.1.17) we see that c(x; t) rapidly
increases whereas f(x; t) decreases to zero in nite time. This is in accord with the observation that enzyme
release is greatest at the penetration site where the bronectin is weakest.
Conversely if a < 0, then sprouts do not form (the collapse case) and c(x; t) tends to zero and f(x; t)
rapidly increases. This is also in good agreement with observations.
It is clear then that the simple model consisting of the rst two equations in (3.1.1) and the approx-
imate equation (3.1.2) together with the corresponding boundary condition, even without proliferation of
bronectin and chemotactic sensitivity is able to reproduce the early stages of capillary formation initiating
the angiogenesis process.
3.2. Angiogenic factor driven case. In this section we consider the full system (2.2.23)-(2.2.24). We no-
tice that angiogenic factor is always decreasing while proteolytic enzyme could increase or decrease. However
we always have
@
@t
(c + v) =  c:(3.2.1)
Thus the quantity in large parentheses is not increasing. It also tells us that we may express the angiogenic
variable v(x; t) in terms of c; v
0
; c
0
and
R
t
0
c dt:
This is the starting point for our simplied analysis. Following the argument of the preceding subsection,
we are lead to rst consider the system
@
@t
=
@
@x


@
@x

ln

^


;
@v
@t
=  v;
@c
@t
= v;
@f
@t
= (   )f
(3.2.2)
where we have set  =  = 0: From (3.2.1) we obtain
c(x; t) = c
0
(x) + [v
0
(x)  v(x; t)]:(3.2.3)
We set
(x) = v
0
(x) + c
0
(x)  v
0
(x)(3.2.4)
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with strict inequality wherever c
0
is strictly positive somewhere.
Therefore as long as the proteolyic enzyme concentration is smaller than , it will increase at the expense
of angiogenic factor. In this case, we then have
^ (c; v; f) = [(x)  v(x; t)]

0
=D
f
 =D
(x; t)):(3.2.5)
We cannot complete the reduction of the rst of equations (3.2.2) to as simple an equation in  as in the
preceding subsection because now the ratio c
x
=c takes the form
c
x
(x; t)
c(x; t)
=

0
(x)   v
x
(x; t)
(x)  v(x; t)
and the right hand side of this will involve exp( ) also.
However, we can make a few observations about the full system (2.2.23)-(2.2.24),
Suppose we know that (x; t)! 
1
(x) as t! +1 and that 
1
is positive on [0; 1] and smooth. Then we
know that f ! 0 and v ! 0 uniformly on [0; 1] as t! +1: If  = 0 we know that we must therefore have
c(x; t)! (x): Assuming that f
x
! 0 also, (which is at least what the numerical experiments indicate), we
must have

0
1
(x)

1
(x)
=
@
@x
ln


1
+ (x)

2
+ (x)


1
which in turn tells us that for some constant  > 0

1
(x) = 


1
+ (x)

2
+ (x)


1
(3.2.6)
However, to get more information, we have to resort to numerics.
3.3. A Remark on Mitogenesis. In order to allow for the mitogenic eect of the proteolytic factor, we
should replace the rst equation in (2.2.21) by the equation
@
@t
= D
@
@x


@
@x

ln

^


+ (c(x; t)  c(x; 0))(
1
  )(3.3.1)
or by the equation
@
@t
= D
@
@x


@
@x

ln

^


+ maxf0; [c(x; t)  c(x; 0)]g(
1
  ):(3.3.2)
where  is a rate constant for EC production and 
1
is some maximal EC density which cannot be exceeded
by endothelial cells.
Notice that in (3.3.1) we are suggesting that endothelial cells will proliferate or be consumed according
as the proteolytic factor exceeds or falls below its initial value. However, in the absence of enzymatic factor,
we would not expect any "conversion" of cells. Therefore, we reject this model.
However, in (3.3.2), no EC proliferation will occur unless the factor exceeds its initial value although if
the proteolytic enzymatic factor falls below its initial value no EC (or proteolytic enzyme) will be consumed.
In both (3.3.1) and (3.3.2) the underlying assumption (in so far as the coecient of  is concerned) is
that the rate of production of endothelial cells or proteolytic enzyme is a second order reaction, at least for
small values of : However, it could be that this production is only rst order. That is, the production of
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EC is sensitive to the presence of excess proteolytic enzymatic factor but not its amount. In this case, we
would replace (3.3.2) by the equation
@
@t
= D
@
@x


@
@x

ln

^


+ maxf0; sgn[c(x; t)  c(x; 0)]g(
1
  ):(3.3.3)
where sgn(x) denotes the sign of x if x 6= 0 and is zero otherwise. order, it seems worthwhile to at least
consider calculations based on (3.3.3).
Since it is easy to modify our programs to include mitogenic eects, and since including such terms
in our calculations here would only mask the eects of the random walk model, we shall not include any
computations in this paper based on the equations in this remark. However, we will include the eects of
mitogenesis when we consider the full model which will include branching of the capillary sprouts into the
ECM in a forthcoming work.
4. Numerical Experiments
4.1. Auto-enzyme production case. In this section we present some numerical computations for the
system (2.2.21) together with initial conditions
 (x; 0) = 
0
> 0;
c (x; 0) = c
0
(1   cos(2x)) > 0;
f (x; 0) = f
0
> 0:
(4.1.1)
where now 
0
; c
0
; f
0
are all constant. We use the choices for ^ given by (2.2.11)-(2.2.15) or by (2.2.19).
The idea here is to present to the vascular wall an initial non constant proteolytic enzyme prole (which
may have caused a short time earlier by the cell's response to one of the angiogenic factors) and then follow
the change in EC density, enzyme concentration and laminar thickness via the dynamical equations (2.2.21).
We have taken the initial data such that (4.1.1) holds initially. Our numerical computations require that

x
; c
x
; f
x
vanish at x = 0;  and consequently, (4.1.1) holds for later times.
We summarize the results of our numerical experiments:
1. Here we use equations (2.2.21) and (4.1.1) and (2.2.11)-(2.2.15) with  = 0: We can take  = 0 after
suitably replacing c by ce
t
: If this is not done, the numerics will show an initial decrease in c when

0
   < 0:
1a. With the choices given in the gure caption for Figures 3.1Da > 0 and we expect blowup. Indeed,
as we have seen for the exact solution, this is the case. Here we get a single peak. however, the
initial proteolitic enzyme concentration, c(x; 0) = 0:2 0:1 cos(2x) is not very small near the ends
of the interval. Consequently, initially, there is not much variation in the sensitivity ratio c
x
=c
over the interval [0; 1]:
1b. The set of Figures 3.2 is generated from the same system as Figure 3.1. The dierence is that we
have now taken  = 0:1995 so that the initial enzyme concentration is very small and the sensitivity
factor c
x
=c is now very large near the ends of the interval. In fact this ratio is very much larger
near the ends than it is near the center. This gives the EC a greater \incentive" to move toward
the center the further from the center they are. The total amount of enzyme is the same. We see
the formation of a double peak.
What is happening here is the following: If the cells are suciently \starved" of enzyme near the
ends, they will tend to \walk" suciently fast toward the center of the capillary to form a double
peak.
Notice that in Figures 3.1c, 3.2c, the basement lamina is strongly degraded near the center of the
interval.
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1c. With the choices given in the gure caption for Figures 4.1, 4.2 Da < 0: (For these choices, we
took  = 0 but  +  < 0:) Since there is no aggregation of endothelial cells here, we would say
that the system is unfavorable for angiogenesis.
2. In Figure 5 we use (2.2.21)and (4.1.1) with (2.2.11), (2.2.15) and with  = 1: This set of gures is
included to test the full power of the Michaeles-Menton like terms in the simplied model. Again
we notice that if the initial enzyme distribution is \blunt", the EC distribution is unimodal in x
(Figure 5.1c) while if the enzyme distribution is initially sharp (c
x
=c large near the ends) then the EC
concentration develops a bimodal (two peaked) prole in x (Figure 5.2c).
The bimodal space (x) section proles occurring in the various plots are somewhat dicult to explain
mathematically but an explanation along the lines of [15] can be given in terms of the so called \hodograph"
plane. This need not further concern us, but we should be aware of the mathematical phenomenon.
As far as a biological explanation is concerned, it may be that these proles are not realizable in nature.
4.2. Angiogenic factor driven case. In this section we present some numerical computations for the
system (2.2.23) together with initial conditions
 (x; 0) = 
0
> 0;
v (x; 0) = v
0
(1   cos(2x)) > 0;
c (x; 0) = c
0
> 0:
f (x; 0) = f
0
> 0:
(4.2.1)
where now 
0
; v
0
; c
0
; f
0
are all constant. We use the choice for ^ given by (2.2.19).
We began our numerical study with the same set of initial conditions for the simplied system (3.2.2)
with (2.2.11) and (2.2.14). ([3.] below.)
3. In Figures 6.1, we have plotted the EC density, the enzyme density, the bronectin density and the
angiogenic growth factor density for a \blunt" initial distribution of angiogenic growth factor while for
Figures 6.2, a more peaked initial prole of angiogenic growth factor was used, the total amount being
the same in both cases. (Compare Figures 6.1d, 6.2d.) Although the angiogenic variable v(x; t) does
not appear in the EC equation, a unimodal or bimodal distribution of endothelial cells again occurs if
the sensitivity factor (v
x
=v) has a small variation or a large variation respectively.
Next we experimented with the system (2.2.23) with (2.2.11) and (2.2.14).
4. In Figures 7.1 and 7.2 we xed the initial variation but now examined what happens when we change
the bronectin parameters. When = = 0:4 we have a unimodal distribution of EC (Figure 7.1a) but
when = = 0:1 we obtain a bimodal distribution of EC (Figure 7.2a). The behavior of the bronectin,
enzyme and growth factor concentrations are unchanged except for the rates of growth and decay. of
5. In Figures 7.3 and 7.4 we experimented with the eect of the constant k
3
(= ) in our full Michaelis-
Menton mechanism (2.1.2). Notice (Figure 7.3b, 7.4b) that the proteolytic enzyme is being consumed
rather growing (Figure 7.1b, 7.2b) as we would expect. Notice also the bimodal distribution of EC
concentration in Figure 7.4b which is due to the combined eect of a smaller = ratio and a more
peaked initial distribution of v(x; t):
Finally, we conducted experiments with (2.2.23),(2.2.19). We wanted to see what would happen if  = 0,
0 <  <  and  < :
6. In Figures 8.1, we have  = 0; in Figures 8.2, 0 <  <  and in Figures 8.3,  < :
6a. In all three Figures 8.1a, 8.2a and 8.3a, a bimodal distribution forms in the EC density which then
coalesces into a unimodal distribution, but in the latter two gures, the EC density becomes very
focused.
6b. In Figures 8.2b, 8.3b, as the enzyme density drops to zero, it forms a prow shaped region with a
ridge (only half the gure is shown in 8.3b) which is more pronounced in the latter gure. This is
due to the fact that the enzyme is being consumed more rapidly in the latter case.
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6c. In all three Figures 8.1c, 8.2c and 8.3c, There is decay of bronectin with time, However, in the
latter two gures, there is a double trough which coalesces into a single trough just as the EC
ridges coalesce into a single ridge. The troughs become more pronounced the larger the rate of
absorption of enzyme. (Compare 8.2c, 8.3c.)
6d. In all three Figures 8.1d, 8.2d and 8.3d, the form of decay of the growth factor is roughly the same.
5. Cautionary note on numerics
Numerical computations with these models can sometimes give misleading information. In our program
we used a simple explicit marching procedure. For the standard heat equation, this procedure will be stable
if   (x)
2
=Dt is smaller than 0:5: However, for nonlinear problems of the type considered here, this
criterion must be modied and the modied criterion checked at each time step. While we did not do this
here since it slows running time, we reran the program at various values of this ratio. Features of the plots
that persisted are presumed to be present in the actual solution while features that depend on the step sizes
are assumed to be artifacts of the numerics.
As a check on our numerics, we calculated
I(t) 
Z
1
0
(x; t) dx
as
I(t) 
1
N
N
X
i=1
(i=N; t)
which, in the absence of cell proliferation should be constant. we found I(0) = 1; I(0:0250) = 0:9992;
I(0:125) = 0:9882; I(:2500) = 0:9874; I(0:3750) = 0:9871; I(5000) = 0:9868 I(0:6250) = 0:9866 which is less
than a 1.3% loss.
6. Several Proteolytic Enzymatic /Haptotatic factors
The ideas of Section 2 easily extend to the case when the several angiogenic factors are responsible for
one or more enzymes which contribute to the degradation of the basal lamina. Suppose that we have several
\proteolytic species PE
1
;    ; PE
N
: We denote their concentrations by c
1
; c
2
;    ; c
N
: Suppose that the
basement lamina is composed of several dierent haptotatic species and let their densities be denoted by
f
1
;    ; f
M
: Let us take the transition probability rate function to be of the form:
 (f
1
; : : : ; f
M
; c
1
; : : : ; c
N
) = 
1
1
(f
1
)
1
(f
2
)    
1
(f
M
)
2
1
(c
1
)
2
2
(c
2
)    
2
N
(c
N
):(6.1)
We shall suppose that each 
1
j
(x) = x

(1)
j
and 
2
i
(x) = x

(2)
i
for the appropriate ranges of indices.
6.1. Auto-enzyme production case. At rst, let us suppose that for each chemical species there is a
\Michaelis-Menton" type rate law:
@c
i
@t
=

i
c
i

1 + 
i
c
i
  
i
c
i
; for i = 1; : : : ; N(6.1.1)
in place of the rst equation in (2.2.9).
For each haptotatic agent there is a production-consumption law:
@f
j
@t
= 
j
(1  f
j
)f
j
   
j
f
j
 for j = 1; : : : ;M(6.1.2)
in place of the rst equation in (2.2.8) We make no assumption on the signs of the constants 
(i)
j
; 
i
or the
dierences 
j
  
j
: All other constants will be assumed to be positive or perhaps zero.
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Naturally, we still have the master equation (2.2.7) and the boundary condition (2.2.10). However, there
will now need to be prescribed several initial conditions in place of the second equation in each of (2.2.9),
(2.2.8).
Rather than look at (2.2.7) together with (6.1.1) and (6.1.2), let consider (2.2.7) together with the following
simplied versions of (6.1.1) and (6.1.2):
@c
i
@t
= 
i
c
i
   
i
c
i
; for i = 1; : : : ; N(6.1.3)
and
@f
j
@t
= (
j
  
j
)f
j
 for j = 1; : : : ;M:(6.1.4)
For simplicity and to prevent arguments, we shall assume that the constants 
(i)
j
; 
i
; 
j
  
j
are all non
vanishing.
We see that for arbitrary positive functions of x; say d
i
(x); e
j
(x) we have
(x; t) =
1

(1)
i
@
@t
fln[f
j
] + ln[e
j
(x)]gg =
1

(2)
i
@
@t

ln[c
i
e

i
t
] + ln[d
i
(x)]]
	
(6.1.5)
where we have redened 
(1)
j
 
j
  
j
and 
(2)
i
 
i
for notational convenience.
If we set
 (x; t)    (x; 0) =
Z
t
0
(x; s) ds;(6.1.6)
then we can write
@
@x
ln[ (f
1
; ::; f
M
; c
1
; :::; c
N
)] =
0
@
M
X
j=1

(1)
j

(1)
j
+
N
X
i=1

(2)
i

(2)
i
1
A
 
x
  
x
(6.1.7)
where  denotes the coecient of  
x
in the middle term. Now, provided the sum  is not zero and we
chose  (x; 0) such that
 
x
(x; 0) =  
1

0
@
M
X
j=1

(1)
j

(1)
j
e
0
j
(x)
e
j
(x)
+
N
X
i=1

(2)
i

(2)
i
d
0
i
(x)
d
i
(x)
1
A
;(6.1.8)
 must satisfy
L   
tt
+  ( 
x
 
t
)
x
=  
xxt
(6.1.9)
which is the same as (3.1.8) with a = : From our prior work with (6.1.9) we know that there will be
solutions which blow up in nite time if a > 0 and that if a < 0, solutions will collapse to a constant in
innite time. We say therefore that the system (2.2.7), (6.1.1), (6.1.2) is favorable for angiogenesis if and
only if
 =
M
X
j=1

(1)
j

(1)
j
+
N
X
i=1

(2)
i

(2)
i
> :0(6.1.10)
Thus, we shall say that a single a chemotactic or haptotatic factor is said to be favorable for angiogenesis
if and only if 
(k)
j

(k)
j
> 0: Likewise we can say that a factor is unfavorable for angiogenesis or agiostatic if
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and only if for that factor 
(k)
j

(k)
j
< 0: In accordance with medical terminology, we shall call such a factor
an angiostatin.
In section 2 we have considered the situation in which we have a single chemical agent and a single
haptotatic agent. We assumed that the chemotactic agent was favorable for angiogenesis. The haptotatic
agent will be favorable for angiogenesis if     > 0: Of course if one agent is favorable for angiogenesis
and the other is not, then angiogenesis cannot occur (according to this model at least) unless the  sum is
positive.
It follows from (6.1.5)-(6.1.6) that
f
j
(x; t) = f
j
(x; 0)e

(1)
j
( (x;t)  (x;0))
for j = 1; : : : ;M:(6.1.11)
c
i
(x; t) = c
i
(x; 0)e
 
i
t
e

(2)
i
( (x;t)  (x;0))
for i = 1; : : : ; N:(6.1.12)
with  (x; 0) prescribed. If we use the exact solution for (3.1.8) with a = ; we take  (x; 0) =   ln[1 +
a
2

2
  2a cosNx]
Thus, if a > 0; and  blows up in nite time, then the same will be true for  and the concentrations or
densities of all the proteolytic enzymatic or haptotatic factors for which 
(i)
j
> 0 while for those factors for
which the rate constants 
(i)
j
< 0; th concentrations or densities will collapse to zero in nite time.
Of course it is not as easy to solve (2.2.7), (6.1.1), (6.1.2). We must resort to numerical computations in
general.
6.2. Angiogenic factor driven case. Here we imagine that several angiogenic factors are responsible for
producing one or more proteolytic enzymes. One could have several Michaelis-Menton mechanisms of the
form
V
i
+R
i
k
i
 1

k
i
1
R
i
V
i
(6.2.1)
R
i
V
i
k
i
2
 ! C
i
+R
i
C
i
k
i
3
 ! Q
i
Corresponding to each of these we would have a pair of ordinary dierential equations of the form given in
(2.1.4) for each such mechanism. Since we cannot produce exact solutions (even for a simplied model as
discussed Section 3. On the other hand, the mechanism(s) described in (2.1.2)(resp. (6.2.1)) are only overall
mechanisms.
7. Summary
In this paper we have set out to describe the essential features of angiogenesis in general and to tumor
angiogenesis in particular.
We have proposed a new mathematical model based on two essential ideas:
A. The notion that endothelial cell migration is essentially a \diusive" process based on the notion
of reinforced random walks. An essential ingredient in this notion is the incorporation of transition
probabilities which \reinforce" the walking. These transition probabilities are taken to be functionally
dependent on the proteolytic enzymes which stimulate cell movement and upon variations in the density
of bronectin in the vessel wall.
B. The proteolytic enzymes themselves are regarded as the products of a catalytic \reaction" of angiogenic
factors with the cell of Michaelis-Menton type. The \catalyst" for this reaction is taken to be the
receptor molecules which project from the cell interior through the membrane.
We analyzed this model as follows.
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B-1. We examined the simple sub-case of [B] in which proteolytic enzyme is self generated in response to
some non-chemical stimulus of unknown origin. However, the production rate equation for the enzyme
was taken to be of saturation form. This ordinary dierential equation was then combined with a
\production" equation for bronectin coupled with the random walk partial dierential equation in
[A].
B-2. We then examined the full model described in [B] in which the two classical Michaelis-Menton ordinary
dierential equations were combined with a \production" equation for bronectin coupled with the
random walk partial dierential equation in [A].
Both the models [B-1] and [B-2] showed that when the initial total variation of the concentration dis-
tribution of enzyme ([B-1]) or growth factor [(B-2]) was small, the endothelial cells aggregate to form a
unimodal distribution. However, when the total initial variation of either concentration was large, the initial
aggregation was bimodal which then coalesced into a unimodal distribution. In either case, the numerical
experiments indicate a breakdown in bronectin as proteolitic enzyme forms and is then consumed.
8. Discussion-Future Work
The processes involved in gaining a fuller understanding of angiogenesis is complex and not well under-
stood. For example, we have not addressed the eects on our results if haptotatic saturation of bronectin
is taken into account as well as its proliferation. Nor have we addressed the role of the mast cells, the
macrophage cells and the pericyte cells. These aspects will be the subject of further work. In addition there
is also the fundamental problem of linking the capillary sprout model to modeling angiogenesis within the
ECM. Work in this direction is in progress and will be reported in due course.
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Figure Captions
Figure 1. From[14]. Notice the narrower penetrating endothelial cell.
Figure 2. Sequential steps for vascular growth [24].
Figure 2a. Normal capillary.
Figure 2b. Onset of angiogenesis.
Figure 2c. Channel formation.
Figure 2d. Notice the anastomosis (capillary loop).
Figure 3.1 Here we take  = 0:4;  = 1; 
0
= 1:0 and  = 0 <  = 1:5 We also used 
0
= 1; c
0
= 0:2;  = 0:1 and
f
0
= 1; 
0
=  = D: Then a > 0: (In these and the computations below, D = 0:04:)
Figure 3.2 Here we use the same data as in Figure 3 with the exception that we now take  = 0:1995:
Figure 4.1 We have the same constants as above except now we take  = 1;  =  1:5 so that a < 0:
Figure 4.2 We have the same constants as above except now we take  =  1:5;  = 1 so that a < 0:
Figure 5.1 Here we have used the full system (2.2.21) and (4.1.1) with (2.2.11) and (2.2.14). Values we have
changed from the previous gures are as follows: Here  = 1:0;  = 5; 0  = 10:0;  = 1:0; and  = 1:0:
We also used 
0
= 1; c
0
= 0:2;  = 0:1 and f
0
= 1:
Figure 5.2 . These gures were generated with the same data as Figures 5.1 except that now  = 0:1995:We now
have a double singularity forming in the EC concentration.
Figure 6.1 Here we use the simplied system (3.2.2) with (2.2.11) and (2.2.14). We take  = 0,  = 5:0; 
0
= 1:0;
c
0
= 1:5;  = 0:2: and  = 50:
Figure 6.2 These gures were generated with the same data as Figures 6.1 except that now  = 1:5:
Figure 7.1 Here we use the system (2.2.23) with (2.2.11) and (2.2.14). We take  = 2:0,  = 5:0; 
0
= 1:0;
v
0
= 1:5; c
0
= 0:5;  = 0:2:  = 10;  = 0; and  = 50:0:
Figure 7.2 The same data as in the previous gure except that now  = 1:0,  = 10:0. The corresponding gures
7.2b,c,d are not shown as they are similar to gures 7.1b,c,d
Figure 7.3 We take the same data as in Figure 7.1 except that now we have k
3
=  = 20: The corresponding
gures 7.4b,c,d are not drawn as they are similar to 7.3b,c,d.
Figure 7.4 Here we use the system (2.2.23) with (2.2.11) and (2.2.14). We take the same data as in Figure 7.215
except that now we have  = 1:0;  = 20:0 and  = 25:0; = 0:6
Figure 8.1 Here we use the system (2.2.23) with (2.2.19). We take 
1
= 0:001; 
2
= 1:0; 
1
= 1:000; 
2
= 1:00;

1
= 
2
= 1:0;  = 4:0  = 5:0;  = 50:0;  = 10:0 and v
0
=  = 1:25 f
0
= 1:0; 
0
= 1:0; c
0
= 0:5 and
 = 0:0:
Figure 8.2 Here we use the system (2.2.23) with (2.2.19) and the same data as in Figure 8.1 but now  = 20:0:
Figure 8.3 Here we use the system (2.2.23) with (2.2.19) and the same data as in Figure 8.1 but now  = 70:0:
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